GASTROINTESTINAL NEUROENDOCRINE TUMOR
Clinical trials for GASTROINTESTINAL NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against tough cancers in early trial
Disease control OngoingThis Phase 2 trial tests an oral drug called ESK981 in people with advanced pancreatic cancer, neuroendocrine tumors, or neuroendocrine prostate cancer. The goal is to see if the drug can keep the cancer from growing for at least 4 months. Participants take the drug for 5 days, t…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug E7386 tested for tough cancers
Disease control OngoingThis early-phase study tests a new drug called E7386 in about 70 people with advanced solid tumors, including colorectal cancer. The main goal is to check safety and find the right dose. Participants have tumors that no longer respond to standard treatments.
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Which scan spots hidden tumors best? new study aims to find out
Diagnosis OngoingThis study compares three different PET/CT scans (68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG) in 50 people with metastatic neuroendocrine tumors. The goal is to see if all tumors show up on the standard scan or if some are missed, which could change treatment. Participants will get …
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC